The Use of An EHR Patient Portal (Mychart-Epic) in Patients With Inflammatory Bowel Disease

被引:11
|
作者
Reich, Jason [1 ]
Canakis, Andrew [1 ]
Shankar, Divya [1 ]
Harrington, Jill [1 ]
Apte, Manisha [1 ]
Weinberg, Janice [2 ]
Jones, Eric [2 ]
Noronha, Ansu [1 ]
Wasan, Sharmeel K. [1 ]
Farraye, Francis A. [1 ,3 ]
机构
[1] Boston Med Ctr, Sect Gastroenterol, Boston, MA USA
[2] Boston Univ, Biostat, Boston, MA 02215 USA
[3] Mayo Clin, Div Gastroenterol & Hepatol, Inflammatory Bowel Dis Ctr, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA
关键词
ulcerative colitis; Crohn's disease; electronic health record; vaccination; quality of life; patient portal;
D O I
10.1093/crocol/otz039
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Inflammatory bowel disease (IBD) has a significant effect on patients' overall quality of life (QoL). We hypothesized that an Electronic Health Record (EHR) patient portal (EPIC's Mychart) can be utilized to improve QoL in IBD patients and increase vaccine uptake. Methods: Patients were randomized to receive specific disease (INT) information and to a control arm (CTRL) that received periodic non-IBD related messages. Disease severity was assessed using the Harvey-Bradshaw index, and Simple Clinical Colitis Activity index. QoL was measured using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). Secondary outcome measures included overall satisfaction with the portal and influenza and pneumococcal vaccine uptake. Results: One hundred twenty-seven patients were randomized: At baseline the CTRL group had a statistically significant higher QoL (Median SIBDQ 53.7) compared with the INT group (median SIBDQ 49.3), P = 0.04. At 6 months, the INT group had a trend towards a significantly greater increase in QoL (median SIBDQ 58) when compared with the CTRL group (median SIBDQ 57.5), P = 0.06. At 6 months more frequent portal use showed a significantly lower median SIBDQ (median 53) compared with patients with less frequent portal use (median 59), P = 0.038. At 6 months 88% of patients felt that the MyChart portal was useful with respect to IBD management. Patients had high rates of portal utilization with one-third of patients logging on weekly, and one-third logging on monthly. With respect to vaccine uptake, both influenza and pneumococcal pneumonia had higher rates of vaccine uptake. Conclusions: Patients showed a trend towards improved QoL after receiving disease-specific information through our EHR portal. A significant increase in vaccine uptake was also seen. Frequent automated messages sent via an EHR portal can improve patient's overall QoL. Larger studies will be needed to determine if automated portal reminders have a significant association with improved QoL, and furthermore to determine if there is any impact on disease activity.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] THE USE OF AN EMR PATIENT PORTAL (MYCHART-EPIC) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS OF A RANDOMIZED CLINICAL TRIAL
    Reich, Jason
    Canakis, Andrew
    Shankar, Divya
    Apte, Manisha
    Weinberg, Janice
    Jones, Eric A.
    Noronha, Ansu
    Wasan, Sharmeel K.
    Farraye, Francis A.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S436 - S436
  • [2] The Use of an EMR Patient Portal (MYCHART-EPIC) in Patients With Inflammatory Bowel Disease: Preliminary Results of a Randomized Clinical Trial
    Reich, Jason
    Harrington, Jill E.
    Shankar, Divya
    Jones, Eric
    Weinberg, Janice
    Norohna, Ansu
    Wasan, Sharmeel K.
    Farraye, Francis A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S348 - S348
  • [3] INCREASING VACCINATION RATES WITH A PATIENT PORTAL (MYCHART-EPIC) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS OF A RANDOMIZED CLINICAL TRIAL
    Canakis, Andrew
    Reich, Jason
    Shankar, Divya
    Jones, Eric A.
    Weinberg, Janice
    Noronha, Ansu
    Wasan, Sharmeel K.
    Farraye, Francis A.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S29 - S29
  • [4] Patients' Characteristics Effecting the Use of a MyChart Patient Portal
    Ahmed, Ali
    Nasralah, Tareq
    Wahbeh, Abdullah
    Noteboom, Cherie B.
    [J]. PROCEEDINGS OF THE 52ND ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, 2019, : 3974 - 3979
  • [5] PREDICTORS OF MYCHART® MESSAGING USE IN AN INFLAMMATORY BOWEL DISEASE POPULATION
    Lutz, Megan
    Matthews, Lindsay A.
    Tuan, Wen-Jan
    Saha, Sumona
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S416 - S417
  • [6] MYCHART MESSAGE USE DOES NOT OFFSET PHONE ENCOUNTERS OR OFFICE VISITS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hristov, Alexander D.
    Kalra, Amandeep
    Alberth, Julia B.
    Li, Zhanhai
    Caldera, Freddy
    Saha, Sumona
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S796 - S797
  • [7] Portal hypertension in patients with inflammatory bowel disease
    Leal-Valdivieso, Carles
    Naves, Juan E.
    Manosa, Miriam
    Zabana, Yamile
    Cabre, Eduard
    Domenech, Eugeni
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2010, 33 (04): : 297 - 302
  • [8] MyChart application in addressing Inflammatory Bowel Disease patients' concerns and impact on service utilisation
    Raman, K. P.
    Agorogianni, A.
    Hadjinicolaou, A.
    Nightingale, A.
    Mayhew, A.
    Munro, R.
    Raine, T.
    McDermott, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S434 - S435
  • [9] PATIENT ACTIVATION IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Kanu, C. N.
    Brown, C. M.
    Bamer, J. C.
    Chapman, C. J.
    Walker, H. A.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A229 - A229
  • [10] Cannabis use by patients with inflammatory bowel disease
    Lal, Simon
    Ryan, Manijeh
    Tangri, Sabrena
    Silverberg, Mark S.
    Gordon, Allan
    Steinhart, A. H.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A183 - A183